Leanne Woods-Burnham to Cell Line, Tumor
This is a "connection" page, showing publications Leanne Woods-Burnham has written about Cell Line, Tumor.
Connection Strength
0.320
-
Hooker SE, Woods-Burnham L, Bathina M, Lloyd S, Gorjala P, Mitra R, Nonn L, Kimbro KS, Kittles RA. Genetic Ancestry Analysis Reveals Misclassification of Commonly Used Cancer Cell Lines. Cancer Epidemiol Biomarkers Prev. 2019 06; 28(6):1003-1009.
Score: 0.104
-
Woods-Burnham L, Cajigas-Du Ross CK, Love A, Basu A, Sanchez-Hernandez ES, Martinez SR, Ortiz-Hern?ndez GL, Stiel L, Dur?n AM, Wilson C, Montgomery S, Roy S, Casiano CA. Glucocorticoids Induce Stress Oncoproteins Associated with Therapy-Resistance in African American and European American Prostate Cancer Cells. Sci Rep. 2018 10 10; 8(1):15063.
Score: 0.101
-
Woods-Burnham L, Basu A, Cajigas-Du Ross CK, Love A, Yates C, De Leon M, Roy S, Casiano CA. The 22Rv1 prostate cancer cell line carries mixed genetic ancestry: Implications for prostate cancer health disparities research using pre-clinical models. Prostate. 2017 Dec; 77(16):1601-1608.
Score: 0.095
-
Basu A, Woods-Burnham L, Ortiz G, Rios-Colon L, Figueroa J, Albesa R, Andrade LE, Mahler M, Casiano CA. Specificity of antinuclear autoantibodies recognizing the dense fine speckled nuclear pattern: Preferential targeting of DFS70/LEDGFp75 over its interacting partner MeCP2. Clin Immunol. 2015 Dec; 161(2):241-50.
Score: 0.020